Patient-Reported Outcomes from IMfirst: Chemotherapy Plus Atezolizumab in a Real-World Setting of Extensive-Stage SCLC-MedSci.cn

Patient-Reported Outcomes from IMfirst: Chemotherapy Plus Atezolizumab in a Real-World Setting of Extensive-Stage SCLC

Gómez, MD; Dols, MC; de Castro, J; Vega, AM; Aix, SP; Arriola, E; Carcereny, E; Tarruella, MM; Vence, GH; González, EE; Pradera, JF; Granados, ALO; Morales, MG; Sureda, BM; Vilà, L; Cordellat, AB; Fajardo, CA; Crama, L; Lerones, N; Campelo, RG

JOURNAL OF THORACIC ONCOLOGY, 2023; 18 (11): S370

科室
- - 订阅+
  - 更多科室
工具
服务